XORTX Therapeutics Inc.
NASDAQ: XRTX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Allen Warren Davidoff
- Employees
- 2
- Headquarters
- Vancouver, Canada
- IPO year
- 2021
- Market cap
- $587.6K
- Website
- https://www.xortx.com
Loading XRTX…
Loading profile data…Frequently asked questions about XRTX
What does XORTX Therapeutics Inc. (XRTX) do?
XORTX Therapeutics Inc. is a biopharmaceutical firm dedicated to advancing and bringing to market medical treatments targeting a range of conditions, including chronic kidney ailments, diabetes, insulin resistance, metabolic syndrome, diabetic nephropathy, and various infections. Their pipeline includes XRx-008, a late-stage clinical program des...
Where does XRTX trade?
XORTX Therapeutics Inc. (XRTX) trades on the NASDAQ Capital Market.
What sector is XRTX in?
XORTX Therapeutics Inc. (XRTX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of XORTX Therapeutics Inc.?
Allen Warren Davidoff is the chief executive officer of XORTX Therapeutics Inc. (XRTX).
Where is XORTX Therapeutics Inc. headquartered?
XORTX Therapeutics Inc. is headquartered in Canada.
Does XRTX pay a dividend?
XORTX Therapeutics Inc. (XRTX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did XRTX go public?
XORTX Therapeutics Inc. (XRTX) completed its initial public offering in 2021.